← Browse by Condition
Medical Condition
cataract
Total Trials
13
Recruiting Now
13
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for cataract sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cataract Clinical Trials
How many clinical trials are currently recruiting for cataract?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for cataract, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cataract?
cataract research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cataract clinical trial?
Eligibility criteria for cataract trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07080229 Phase 3
Recruiting
Enrollment
126 pts
Location
Egypt
Sponsor
Suez Canal University
NCT06555289
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
Juliette Eye Institute Researc...
NCT06966167
Recruiting
Enrollment
120 pts
Location
China
Sponsor
Eye & ENT Hospital of Fudan Un...
NCT06624826
Recruiting
Enrollment
60 pts
Location
Austria
Sponsor
Prim. Prof. Dr. Oliver Findl, ...
NCT06844292
Recruiting
Enrollment
152 pts
Location
Austria
Sponsor
Medical University of Graz
NCT03713268
Recruiting
Enrollment
262 pts
Location
United States
Sponsor
Duke University
NCT07610226
Recruiting
Enrollment
35 pts
Location
United States
Sponsor
Laser Defined Vision
NCT07648355
Recruiting
Enrollment
40 pts
Location
United States
Sponsor
OVO LASIK + Lens
NCT06482996
Recruiting
Enrollment
80 pts
Location
Turkey (Türkiye)
Sponsor
Umraniye Education and Researc...
NCT06743594
Recruiting
Enrollment
1,000 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT06891092
Recruiting
Enrollment
100 pts
Location
Poland
Sponsor
Medical University of Bialysto...
NCT07183891
Recruiting
Enrollment
100 pts
Location
China
Sponsor
Jin Yang
NCT07609186
Recruiting
Enrollment
60 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology